Azenosertib
ZN-c3-004
Phase 2 small_molecule active
Quick answer
Azenosertib for Uterine Serous Carcinoma is a Phase 2 program (small_molecule) at Zentalis Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Zentalis Pharmaceuticals
- Indication
- Uterine Serous Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active